Joanna Huang
About
Joanna Huang is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery.
According to data from OpenAlex, Joanna Huang has authored 37 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Joanna Huang's work include Diabetes Treatment and Management (14 papers), Heart Failure Treatment and Management (12 papers) and Diabetes Management and Research (7 papers). Joanna Huang is often cited by papers focused on Diabetes Treatment and Management (14 papers), Heart Failure Treatment and Management (12 papers) and Diabetes Management and Research (7 papers). Joanna Huang collaborates with scholars based in United States, United Kingdom and France. Joanna Huang's co-authors include Mette Hammer, George Osei-Assibey, James McDermott, Steven W. Blume, Neil Wintfeld, Michael L. Ganz, Jonathan Bouchard, Pravin Kamble, Amir Goren and Gregg C. Fonarow and has published in prestigious journals such as Journal of the American College of Cardiology, International Journal of Molecular Sciences and European Heart Journal.
In The Last Decade
Joanna Huang
37 papers receiving 845 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Joanna Huang United States | 17 | 332 | 247 | 131 | 112 | 100 | 37 | 859 | ||
| Elias J. Dayoub United States | 13 | 364 1.1× | 308 1.2× | 160 1.2× | 99 0.9× | 69 0.7× | 36 | 909 | ||
| Susan Connolly United Kingdom | 15 | 437 1.3× | 128 0.5× | 216 1.6× | 98 0.9× | 216 2.2× | 38 | 1.1k | ||
| Tracey H. Taveira United States | 20 | 242 0.7× | 457 1.9× | 94 0.7× | 84 0.8× | 94 0.9× | 41 | 1.2k | ||
| Amber E. Johnson United States | 15 | 436 1.3× | 282 1.1× | 116 0.9× | 49 0.4× | 215 2.1× | 56 | 1.2k | ||
| José Fernando Vilela-Martin Brazil | 18 | 588 1.8× | 211 0.9× | 121 0.9× | 49 0.4× | 136 1.4× | 77 | 1.1k | ||
| Soneil Guptha India | 16 | 796 2.4× | 313 1.3× | 111 0.8× | 116 1.0× | 248 2.5× | 32 | 1.2k | ||
| Nilay S. Shah United States | 23 | 707 2.1× | 187 0.8× | 193 1.5× | 67 0.6× | 249 2.5× | 89 | 1.5k | ||
| Torstein Hole Norway | 18 | 435 1.3× | 190 0.8× | 96 0.7× | 75 0.7× | 201 2.0× | 48 | 1.0k | ||
| John A. Merenich United States | 19 | 183 0.6× | 260 1.1× | 264 2.0× | 82 0.7× | 61 0.6× | 39 | 934 | ||
| Ann M. Sheehy United States | 17 | 261 0.8× | 221 0.9× | 126 1.0× | 85 0.8× | 87 0.9× | 44 | 934 |
Countries citing papers authored by Joanna Huang
Since
Specialization
Citations
This map shows the geographic impact of Joanna Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Huang more than expected).
Fields of papers citing papers by Joanna Huang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Joanna Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Huang. The network helps show where Joanna Huang may publish in the future.
Co-authorship network of co-authors of Joanna Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Huang. A scholar is included among the top collaborators of Joanna Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Huang. Joanna Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Townsend, Raymond R., et al.. (2025). Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation. American Journal of Hypertension. 39(1). 161–170.
2.
Spencer‐Bonilla, Gabriela, Jun Fan, Paul Cheng, et al.. (2025). Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration. Journal of the American College of Cardiology. 87(5). 533–545.
3.
Chang, Raymond Chuen‐Chung, et al.. (2024). Benefits of dapagliflozin in chronic kidney disease for US commercial payers: A cost-offset analysis. Journal of Managed Care & Specialty Pharmacy. 30(8). 834–842.
4.
Chang, Raymond Chuen‐Chung, et al.. (2024). Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome. Advances in Therapy. 41(8). 3247–3263.
5.
Kittipibul, Veraprapas, Muthiah Vaduganathan, Karen Chiswell, et al.. (2024). Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy. JACC Heart Failure. 12(8). 1409–1421.
6.
Ghazi, Lama, Yu Yamamoto, Michael Fuery, et al.. (2023). Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. European Heart Journal. 44(40). 4233–4242.
7.
Bhatt, Ankeet S., Gregg C. Fonarow, Stephen J. Greene, et al.. (2023). Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry. Journal of Cardiac Failure. 30(2). 319–328.
8.
Pierce, Jacob B., Muthiah Vaduganathan, Gregg C. Fonarow, et al.. (2023). Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US. JAMA Cardiology. 8(7). 652–652.
9.
Ghazi, Lama, Yu Yamamoto, Ralph J. Riello, et al.. (2022). Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice. Journal of the American College of Cardiology. 79(22). 2203–2213.
10.
McEwan, Phil, et al.. (2022). Cardiorenal disease in the United States: Future health care burden and potential impact of novel therapies. Journal of Managed Care & Specialty Pharmacy. 28(4). 415–424.
11.
Verma, Santosh K., et al.. (2022). Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase. Clinical Epidemiology. Volume 14. 1535–1545.
12.
Lamerato, Lois, Juan José García Sánchez, Like Jiang, et al.. (2021). Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants. Advances in Therapy. 38(2). 1352–1363.
13.
Patel, Ravi B., Gregg C. Fonarow, Stephen J. Greene, et al.. (2021). CLINICAL PROFILES, MEDICAL THERAPIES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HF ACROSS THE SPECTRUM OF KIDNEY FUNCTION: THE GWTG-HF REGISTRY. Journal of the American College of Cardiology. 77(18). 559–559.
14.
Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, et al.. (2021). Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure. Journal of Cardiac Failure. 28(4). 554–563.
15.
Olufade, Temitope, Like Jiang, Rubeen Israni, Joanna Huang, & Aidar R. Gosmanov. (2021). Cardiovascular and renal disease manifestation and healthcare resource utilization in patients on first‐line oral therapy for type 2 diabetes: A claims‐based observational cohort study. Diabetes Obesity and Metabolism. 23(12). 2741–2751.
16.
Patel, Ravi B., Gregg C. Fonarow, Stephen J. Greene, et al.. (2021). Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. Journal of the American College of Cardiology. 78(4). 330–343.
17.
Kamble, Pravin, Jennifer Hayden, Jenna Collins, et al.. (2018). Association of obesity with healthcare resource utilization and costs in a commercial population. Current Medical Research and Opinion. 34(7). 1335–1343.
18.
Kamble, Pravin, Raymond A. Harvey, B. Gabriel Smolarz, et al.. (2017). Positive predictive value between medical-chart body-mass-index category and obesity versus codes in a claims-data warehouse. Current Medical Research and Opinion. 34(1). 117–121.
19.
Kudel, Ian, Joanna Huang, & Rahul Ganguly. (2017). Impact of Obesity on Work Productivity in Different US Occupations. Journal of Occupational and Environmental Medicine. 60(1). 6–11.
20.
Harvey, Raymond A., Jennifer Hayden, Pravin Kamble, Jonathan Bouchard, & Joanna Huang. (2016). A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example. Pharmacoepidemiology and Drug Safety. 26(4). 368–377.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Elias J. Dayoub Breakdown of academic impact, for papers by Susan Connolly Breakdown of academic impact, for papers by Tracey H. Taveira Breakdown of academic impact, for papers by Amber E. Johnson Breakdown of academic impact, for papers by José Fernando Vilela-Martin Breakdown of academic impact, for papers by Soneil Guptha Breakdown of academic impact, for papers by Nilay S. Shah Breakdown of academic impact, for papers by Torstein Hole Breakdown of academic impact, for papers by John A. Merenich Breakdown of academic impact, for papers by Ann M. Sheehy